Drug transport to the brain:: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier

被引:162
|
作者
Demeule, M
Régina, A
Jodoin, J
Laplante, A
Dagenais, C
Berthelet, F
Moghrabi, A
Béliveau, R
机构
[1] Univ Quebec, Hop St Justine, Mol Med Lab, Montreal, PQ H3C 3P8, Canada
[2] Hop Notre Dame de Bon Secours, Dept Pathol, Montreal, PQ H2L 4K8, Canada
[3] Hop St Justine, Unit Hemato Oncol, Montreal, PQ H3T 1C5, Canada
关键词
blood-brain barrier; P-glycoprotein; multidrug resistance; endothelial cells; caveolae;
D O I
10.1016/S1537-1891(02)00201-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The blood-brain barrier (BBB) contributes to brain homeostastis and fulfills a protective function by controlling the access of solutes and toxic substances to the central nervous system (CNS). The efflux transporter P-glycoprotein (P-gp) is a key element of the molecular machinery that confers special permeability properties to the BBB. 2. P-gp, which was initially recognized for its ability to expel anticancer drugs from multidrug-resistant cancer cells, is strongly expressed in brain capillaries. Its expression in the BBB limits the accumulation of many hydrophobic molecules and potentially toxic substances in the brain. 3. The purpose of this review is to summarize the current state of knowledge about the expression of P-gp, its cellular localization as well as its possible functions in the BBB. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:339 / 348
页数:10
相关论文
共 50 条
  • [1] Modeling Substrate Entry into the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier
    Jorgensen, Christian
    Ulmschneider, Martin B.
    Searson, Peter C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (24) : 16615 - 16627
  • [2] Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein
    Morimoto, Kaori
    Nakakariya, Masanori
    Shirasaka, Yoshiyuki
    Kakinuma, Chihaya
    Fujita, Takuya
    Tamai, Ikumi
    Ogihara, Takuo
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (01) : 6 - 9
  • [3] Oseltamivir (Tamiflu™) efflux transport at the blood-brain barrier via P-glycoprotein
    Morimoto, Kaori
    Nakakariya, Masanori
    Kanauchi, Itaru
    Shirasaka, Yoshiyuki
    Tamai, Ikumi
    Ogihara, Takuo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 111 - 112
  • [4] The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery
    Cox, Benoit
    Nicolai, Johan
    Williamson, Beth
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (01) : 113 - 126
  • [5] P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier
    Suzuki, Toyofumi
    Zaima, Chika
    Moriki, Yoshiaki
    Fukami, Toshiro
    Tomono, Kazuo
    JOURNAL OF DRUG TARGETING, 2007, 15 (01) : 67 - 74
  • [6] Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier
    Wanek, Thomas
    Mairinger, Severin
    Langer, Oliver
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4): : 68 - 77
  • [7] P-glycoprotein mediates the efflux of quinidine across the blood-brain barrier
    Kusuhara, H
    Suzuki, H
    Terasaki, T
    Kakee, A
    Lemaire, M
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 283 (02): : 574 - 580
  • [8] Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier
    Matsuzaki, J
    Yamamoto, C
    Miyama, T
    Takanaga, H
    Matsuo, H
    Ishizuka, H
    Kawahara, Y
    Kuwano, M
    Naito, M
    Tsuruo, T
    Sawada, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1999, 20 (02) : 85 - 90
  • [9] P-glycoprotein regulated transport of glutamate at blood-brain barrier
    Liu, XD
    Liu, GQ
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (02): : 111 - 116
  • [10] Modulation of p-glycoprotein transport function at the blood-brain barrier
    Bauer, B
    Hartz, AMS
    Fricker, G
    Miller, DS
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 230 (02) : 118 - 127